S100 based treatment of cardiac power failure

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10792329
APP PUB NO 20160228504A1
SERIAL NO

15026116

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to S100 protein and nuclei acids encoding S100 protein for enhancing the cardiac power as well as vectors and pharmaceuticals comprising the same and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RUPRECHT-KARLS-UNIVERSITAT HEIDELBERGGRABENGASSE 1 HEIDELBERG 69117

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Katus, Hugo Heidelberg, DE 28 142
Most, Patrick Heidelberg, DE 5 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 6, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 6, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00